IL6 and Sepsis: In preclinical studies, TAK-242 showed potent suppressive effects on the production of tumor necrosis factor-α (TNF- α), interleukin-1 (IL-1) and interleukin-6 (IL-6) in both murine [12] and porcine [14] models of sepsis.